• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number PAH090502B
Device Problem Complete Blockage (1094)
Patient Problem Stenosis (2263)
Event Date 05/17/2019
Event Type  Injury  
Manufacturer Narrative
Patient was treated with two devices.Device # 2 pah090502b lot # and udi information not available.It is not known whether both or one device exhibited stenosis.A second report, # 2017233-2020-00186 is being sent to capture patient no.(b)(6).The date the article was accepted is being used as the date of event.
 
Event Description
The following information was reported to gore: in an article titled technical considerations and clinical outcomes in the endovascular management of celiac arterial aneurysms it states two patients who underwent treatment of celiac artery aneurysms who were treated with either gore® viabahn® endoprosthesis with propaten bioactive surface or gore® viabahn® vbx balloon expandable endoprosthesis had device related post-procedural complications: patient no.(b)(6) developed 50-60% in-stent restenosis at the annual follow-up ct and 6 months after the annual follow-up progressed to severe stenosis seen on color doppler ultrasound.Balloon angioplasty was performed to achieve assisted primary stent patency.
 
Event Description
The following information was reported to gore: in an article titled technical considerations and clinical outcomes in the endovascular management of celiac arterial aneurysms it states some patients who underwent treatment of celiac artery aneurysms who were treated with either gore® viabahn® endoprosthesis with propaten bioactive surface or gore® viabahn® vbx balloon expandable endoprosthesis had device related post-procedural complications: patient no.1 developed 50-60% in-stent restenosis at the annual follow-up ct and 6months after the annual follow-up progressed to severe stenosis seen on color doppler ultrasound.Balloon angioplasty was performed to achieve assisted primary stent patency.
 
Manufacturer Narrative
Patient #4 is being reported under mfr report # 2017233-2020-00249.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9832875
MDR Text Key196422727
Report Number2017233-2020-00185
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 04/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/14/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberPAH090502B
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age68 YR
-
-